Angiotensin IV elevates oxytocin levels in the rat amygdala and produces anxiolytic-like activity through subsequent oxytocin receptor activation

Psychopharmacology

Volumn 209, Issue 4, 2010, Pages 303-311

  Beyer, Chad E ^a,b   Dwyer, Jason M ^a   Platt, Brian J ^a   Neal, Sarah ^a   Luo, Bin ^a   Ling, Huai Ping ^a   Lin, Qian ^a   Mark, Robert J ^a   Rosenzweig Lipson, Sharon ^a   Schechter, Lee E ^a  

^a Pfizer Global Research and Development   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Anxiety; At4 receptors; Divalinal; LVV hemorphin 7; Nle angiotensin iv; Oxytocin

Indexed keywords

ANGIOTENSIN ANTAGONIST; ANGIOTENSIN II [3-8]; DIVALINAL; HEMORPHIN 7; HORMONE RECEPTOR BLOCKING AGENT; OPIATE AGONIST; OXYTOCIN; OXYTOCIN RECEPTOR; PEPTIDASE; UNCLASSIFIED DRUG; WAY 162720;

AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; DRUG RECEPTOR BINDING; ENZYME ACTIVITY; ENZYME INHIBITION; EXPERIMENTAL TEST; EXTRACELLULAR SPACE; IMMUNOASSAY; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; TRANQUILIZING ACTIVITY;

AMYGDALA; ANGIOTENSIN II; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BEHAVIOR, ANIMAL; DEPRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; EXPLORATORY BEHAVIOR; HEMOGLOBINS; IMMUNOASSAY; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENTRICULAR; INJECTIONS, SUBCUTANEOUS; LIGANDS; MALE; MICE; MICRODIALYSIS; OXYTOCIN; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ANGIOTENSIN; RECEPTORS, OXYTOCIN; TIME FACTORS; UP-REGULATION;

EID: 77953291694     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-010-1791-1     Document Type: Article

References (34)

1. Albiston AL, Mustafa T, McDowall SG, Mendelsohn FAO, Lee J, Chai SY (2003) AT(4) receptor is insulin-regulated membrane aminopeptidase: potential mechanisms of memory enhancement. Trends Endocrinol Metab 14:72-77 (Pubitemid 36733919)
2. Arletti R, Bertolini A (1987) Oxytocin acts as an antidepressant in two animal models of depression. Life Sci 41:1725-1730 (Pubitemid 18013802)
3. Aran C, Simon P, Larousse C, Boissier JR (1971) Evaluation of a rapid technique for detecting minor tranquilizers. Neuropharmacology 10:459-469
4. Bale TL, Davis AM, Auger AP, Dorsa DM, McCarthy MM (2001) CNS region-specific oxytocin receptor expression: importance in regulation of anxiety and sex behavior. J Neurosci 21:2546-2552
5. Chai SY, Bastias MA, Clune EF, Matsacos DJ, Mustafa T, Lee JH, McDowall SG, Paxinos G, Mendelsohn FA, Albiston AL (2000) Distribution of angiotensin IV binding sites (AT4 receptor) in the human forebrain, midbrain and pons as visualised by in vitro receptor autoradiography. J Chem Neuroanat 20:339-348
6. Chai. SY, Fernando R, Peck. G, Ye SY, Mendelsohn FAO, Jenkins TA, Albiston AL (2004) The angiotensin IV/AT(4) receptor. Cell Mol Life Sci 61:2728-2737
7. Cryan JF, Mombereau C, Vassout A (2005) The tail suspension test as a model for assessing antidepressant activity: review of pharmacological, and genetic studies in mice. Neurosci Biobehav Rev 29:571-625
8. Ferguson JN, Aldag JM, Insel TR, Young LJ (2001) Oxytocin in the medial amygdala is essential for social recognition in the mouse. J Neurosci 21:8278-8285
9. Gard PR, Daw P, Mashhour ZS, Tran P (2007) Interactions of angiotensin IV and oxytocin on behaviour in mice. J Renin Angiotensin Aldosterone Syst 8:133-138 (Pubitemid 350148450)
10. Herbst JJ, Ross SA, Scott HM, Bobin SA, Morris NJ, Lienhard GE, Keller SR (1997) Insulin stimulates cell surface aminopeptidase activity toward vasopressin in adipocytes. Am J Physiol 272: E600-E606
11. Keller SR, Scott HM, Mastick CC, Aebersold R, Lienhard GE (1995) Cloning and characterization of a novel insulin-regulated membrane aminopeptidase from Glut4 vesicles. J Biol Chem 270:23612-23618
12. Kirsch P, Esslinger C, Chen Q, Mier D, Lis S, Siddhanti S, Gruppe H, Mattay VS, Gallhofer B, Meyer-Lindenberg A (2005) Oxytocin modulates neural circuitry for social cognition and fear in humans. J Neurosci 25:11489-11493
13. Kosfeld M, Heinrichs M, Zak. PJ, Fischbacher U, Fehr E (2005) Oxytocin increases trust in humans. Nature 435:673-676
14. Kovacs GL, De Wied D (1994) Peptidergic modulation of learning and memory processes. Pharmacol Rev 46:269-291
15. Krebs LT, Kramar EA, Hanesworth JM, Sardinia MF, Ball AE, Wright JW, Harding JW (1996) Characterization of the binding properties and physiological action of divalinal-angiotensin IV, a putative AT4 receptor antagonist. Regul Pept 67:123-130
16. Lee J, Albiston AL, Allen AM, Mendelsohn FA, Ping SE, Barrett GL, Murphy M, Morris MJ, McDowall SG, Chai SY (2004) Effect of I.C. V injection of AT4 receptor ligands, NLE1-angiotensin IV and LVV-hemorphin 7, on spatial learning in rats. Neuroscience 124:341-349
17. Lee PR, Brady DL, Shapiro RA, Dorsa DM, Koenig JI (2007) Prenatal stress generates deficits in rat social behavior: reversal by oxytocin. Brain Res 1156:152-167
18. Matsumoto H, Rogi T, Yamashiro K, Kodama S, Tsuruoka N, Hattori A, Takio K, Mizutani S, Tsujimoto M (2000) Characterization of a recombinant soluble form of human placental leucine amino- peptidase/oxytocinase expressed in Chinese hamster ovary cells. Eur J Biochem 267:46-52
19. McCarthy MM, McDonald CH, Brooks PJ, Goldman D (1996) An anxiolytic action of oxytocin is enhanced by estrogen in the mouse. Physiol Behav 60:1209-1215
20. Mlynarik M, Zelena D, Bagdy G, Makara GB, Jezova D (2007) Signs of attenuated depression-like behavior in vasopressin deficient Brattleboro rats. Horrn Behav 51:395-405 (Pubitemid 46365691)
21. Neumann ID, Krämer SA, Toschi N, Ebner K (2000) Brain oxytocin inhibits the (re)activity of the hypothalanio-pituitary-adrcnal axis in male rats: involvement of hypothalamic and limbic brain regions. Regul Pept 96:31-38
22. Paxinos G, Watson C (1986) Rat brain in stereotactic coordinates. Academic, San Diego
23. Popik P, Vetulani J, VanRee JM (1996) Facilitation and attenuation of social recognition in rats by different oxytocin-related peptides. Eur J Pharmacol 308:113-116
24. Ring RH, Malberg JE, Potestio L, Ping J, Boikess S, Luo B, Schechter LE, Rizzo S, Rahman Z, Rosenzweig-Lipson S (2006) Anxiolytic-like activity of oxytocin in male mice: behavioral and autonomic evidence, therapeutic implications. Psychopharmacology (Berl) 185:218-225
25. Ring RH, Schechter LE, Leonard SK, Dwyer JM, Platt BJ, Graf R, Grauer S, Pulicicchio C, Resnick L, Rahman Z, Sukoff Rizzo SJ, Luo B, Beyer CE, Logue SF, Marquis KL, Hughes ZA, Rosenzweig-Lipson S (2010) Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonist. Neuropharmacology 58:69-77
26. Ripoll N, Hascoët M, Bourin M (2006) The four-plates test: anxiolytic or analgesic paradigm? Prog Neuropsychopharmacol Biol Psychiatry 30:873-880
27. Rush AJ, Zimmerman M, Wisniewski SR, Fava M, Hollon SD, Warden D, Biggs MM, Shores-Wilson K, Shelton RC, Luther JF, Thomas B, Trivedi MH (2005) Comorbid psychiatric disorders in depressed outpatients: demographic and clinical features. J Affect Disord. 87:43-55
28. Schechter LE, Lin Q, Smith DL, Zhang G, Shan Q, Platt B, Brandt MR, Dawson LA, Cole D, Bernotas R, Robichaud A, Rosenzweig-Lipson S, Beyer CE (2008) Neuropharmacological profile of novel and selective 5-HT6 receptor agonists: WAY-181187 and WAY-208466. Neuropsychophannacology 33:1323-1335 (Pubitemid 351521711)
29. Sofroniew MV (1983) Morphology of vasopressin and oxytocin neurons and their central, vascular projections. Prog Brain Res 60:101-104
30. Stem L, Chermat R, Thierry B, Simon P (1985) The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl) 85:367-370
31. Swanson GN, Hanesworth JM, Sardinia MF, Coleman JK, Wright JW, Hall KL, Miller-Wing AV, Stobb JW, Cook VI, Harding EC et al (1992) Discovery of a distinct binding site for angiotensin II (3-8), a putative angiotensin IV receptor. Regul Pept 40:409-419
32. von Bohlen und Halbach O (2003) Angiotensin IV in the central nervous system. Cell Tissue Res 311:1-9
33. Windle RJ, Shanks N, Lightrnan SL, Ingram CD (1997) Central oxytocin administration reduces stress-induced corticosterone release and anxiety behavior in rats. Endocrinology 138:2829-2834
34. Winslow JT, Insel TR (2002) The social deficits of the oxytocin knockout mouse. Neuropeptides 36:221-229